
Coretag – SUCCESS PAGE – February 26, 2026
Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.

Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.

Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.

A proven, proprietary, scalable technology for converting organic waste into the building blocks of Sustainable Aviation Fuel

A proven, proprietary, scalable technology for converting organic waste into the building blocks of Sustainable Aviation Fuel

Hall of Giants will be a first-of-its-kind cultural institution devoted to celebrating America’s entrepreneurial spirit.

Hall of Giants will be a first-of-its-kind cultural institution devoted to celebrating America’s entrepreneurial spirit.

A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders

A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders

Boost Fertility is on a mission to ensure clinical-grade infertility treatment is affordable and available for anyone who wants it.

Boost Fertility is on a mission to ensure clinical-grade infertility treatment is affordable and available for anyone who wants it.

Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention

Coretag has built a patented Tumor Necrosis Targeting Platform that can be used across many solid cancers.